SCHEMBL87610

SCHEMBL87610

C=CC(S)NC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11568653 0.77
SCHEMBL6396783 0.75
SCHEMBL3128631 0.72
SCHEMBL9576360 0.72
SCHEMBL17909909 0.70
SCHEMBL4445002 0.68
SCHEMBL25477068 0.67
SCHEMBL2790087 0.67
SCHEMBL3857657 0.66 ITGB3 (0.33)
SCHEMBL380024 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298747-A1 Methods and Compositions For Treatment of Nitric Oxide-Induced Clinical Conditions BIO HOLDING, INC. (US) 2009-12-03 US claimed
WO-2014063189-A1 METHODS AND PRODUCTS FOR PREVENTING AND/OR TREATING A STRESS INDUCED CARDIOMYOPATHY ADELAIDE RESEARCH & INNOVATION PTY LTD (AU) 2014-05-01 WO disclosed
US-20120309717-A1 COMPOUNDS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PARP EISAI INC. (US) 2012-12-06 US disclosed
EP-1633362-B1 COMPOUNDS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PARP EISAI INC (US) 2012-09-26 EP disclosed
US-8129382-B2 Compounds, methods and pharmaceutical compositions for inhibiting PARP EISAI INC. (US) 2012-03-06 US disclosed
US-7915280-B2 Compounds and their uses EISAI INC. (US) 2011-03-29 US disclosed
US-20100256095-A1 COMPOUNDS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PARP EISAI INC. (US) 2010-10-07 US disclosed
EP-1339402-B1 AZAPHENANTHRIDONE DERIVATIVES AND THEIR USE AS PARP INHIBITORS EISAI INC (US) 2010-08-25 EP disclosed
US-7750008-B2 Compounds, methods and pharmaceutical compositions for inhibiting PARP EISAI INC. (US) 2010-07-06 US disclosed
US-RE41150-E1 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one EISAI CORPORATION OF NORTH AMERICA (US) 2010-02-23 US disclosed
WO-1999011649-A2 PARP INHIBITORS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS OF USING SAME GUILFORD PHARMACEUTICALS INC. (US) 1999-03-11 WO disclosed
WO-1999011645-A1 POLY(ADP-RIBOSE) POLYMERASE ('PARP') INHIBITORS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING NEURAL OR CARDIOVASCULAR TISSUE DAMAGE GUILFORD PHARMACEUTICALS INC. (US) 1999-03-11 WO disclosed
WO-1999011623-A1 THIOALKYL COMPOUNDS, METHODS, AND COMPOSITIONS FOR INHIBITING PARP ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1999-03-11 WO disclosed
WO-1999011624-A1 OXO-SUBSTITUTED COMPOUNDS, PROCESS OF MAKING, AND COMPOSITIONS AND METHODS FOR INHIBITING PARP ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1999-03-11 WO disclosed
CN-1181700-A Mercapto and seleno derivatives as nitric oxide synthase inhibitors CHILDRENS HOSP MEDICAL CENTER (US) 1998-05-13 CN disclosed
EP-0814792-A1 MERCAPTO AND SELENO DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASE CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1998-01-07 EP disclosed
WO-1997045108-A1 GUANIDINO DERIVATIVES AS INHIBITORS OF THE CYTOTOXIC EFFECT OF PEROXYNITRITE CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1997-12-04 WO disclosed
US-5674907-A Mercapto derivatives as inhibitors of nitric oxide synthase CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1997-10-07 US disclosed
WO-1997032575-A1 MERCAPTO DERIVATIVES AS INHIBITORS OF CYCLOOXYGENASES CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1997-09-12 WO disclosed
WO-1996030007-A1 MERCAPTO AND SELENO DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASE CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1996-10-03 WO disclosed